Platinum Partners
Bayer
Website: https://www.bayer.com/en/
Bayer is a recognized leader in the area of women’s healthcare, with a long-standing commitment to delivering science for a better life by advancing a portfolio of innovative treatments. Bayer offers a wide range of effective short- and long-acting birth control methods as well as therapies for menopause management and gynecological diseases. Bayer is also focusing on innovative options to address the unmet medical needs of women worldwide. Today, Bayer’s research and development efforts focus on finding new treatment options for menopause as well as gynecological diseases and includes several compounds in various stages of pre-clinical and clinical development. Together, these projects reflect the company’s approach to research, which prioritizes targets and pathways with the potential to alter the way that gynecological diseases are treated. Additionally, Bayer intends to provide 100 million women in low-and-middle income countries by 2030 with access to family planning by funding multi-stakeholder aid programs and by ensuring the supply of affordable modern contraceptives. This is part of the comprehensive sustainability measures and commitments from 2020 onwards and in line with the Sustainable Development Goals of the United Nations.
Gedeon Richter
Website: https://www.gedeonrichter.com/en
About Gedeon Richter Plc.:
Health is our mission.
Gedeon Richter Plc. was founded in 1901 and is an innovation-driven specialty pharmaceutical company. The activities of the Hungarian-directed multinational company are vertically integrated and involve pharmaceutical manufacturing, research and development, sales and marketing.
The company is represented in 50 countries worldwide, with 8 manufacturing facilities, and more than 12000 employees.
One of Richter’s most important niche areas is its Women’s Healthcare business with unique and long-term experience in this field. We look after women’s health globally by setting trends in several therapeutical area: female fertility, uterine fibroids / endometriosis, female contraception, vaginal infections, menopause and female technology.
The Company has consistently utilised its pharmaceutical manufacturing facilities to undertake the required complex and lengthy development processes which result in high quality gynaecological products.
By addressing unmet needs and staying ahead of innovation we aim to become the leading provider of pharmaceutical products for European women by the end of the decade.
https://www.gedeonrichter.com/en/areas-of-expertise/womens-healthcare
Conducting our business in a responsible manner is an essential part of our strategy. Developing innovative products and maximising access to them provide direct benefit to patients whilst delivering profitable and sustainable business performance. It allows us to generate value that can, on the one hand, be reinvested in the business and, on the other hand, provide wider society benefits, since healthy people and communities are essential to building healthy societies. Gedeon Richter provides significant contributions to communities worldwide directly through tax payments and charitable activities, and indirectly through the employment of more than 12,000 people.
Gold Partner
Fuji Pharma
Website: www.fujipharma.jp/english/ir/
Fuji Pharma Co., Ltd. is a Japan-based pharmaceutical company listed on the Tokyo Stock Exchange (TSE), mainly engaged in manufacturing and selling prescription pharmaceuticals.
Since our establishment in 1965, Fuji has promoted the corporate philosophy: "We help people lead healthy lives by offering excellent pharmaceuticals." and "Our corporate growth is proportional to our personal growth."
Fuji Pharma has been actively engaged in fields that are considered to have high barriers to entry, such as the production of hormone drugs with difficult manufacturing control and injectable drugs with strict quality control standards. These challenges have formed our foundation, and we have grown as a specialty pharmaceutical company pursuing the fields of women's healthcare, acute medical care, and biosimilars.
The expansion of insurance coverage for infertility treatment in April 2022 added new indications and dosages for 13 ingredients and 19 products by March 2023, of which we have the largest lineup of additional approved products in Japan. With the expansion of insurance coverage, the overall infertility treatment market is expanding, benefitting companies in the segment including Fuji Pharma. We are determined to continue our mission as a specialty pharmaceutical company to help find solution for unmet medical needs in women's health and achieve greater well-being so that all women can feel physically, mentally and socially fulfilled.
Networking Drinks Partner
Male Contraceptive Initiative
Website: https://www.malecontraceptive.org/
Please visit our website for more information.Media Partners
Cambridge Femtech Society
Website: https://www.cambridgefemtech.com/
The Cambridge University Femtech Society aims to create a network of motivated students and alumni who want to promote knowledge-sharing and tackle challenges in femtech - the intersection of women’s health and technology. We strive to give students the opportunity to meet key opinion leaders - entrepreneurs, investors and researchers - operating in femtech. Likewise, we provide femtech companies and investors with the chance to address Cambridge students and researchers who are interested in starting a career in femtech or bringing their femtech ideas to life.
FemTech France
Website: http://femtechfrance.org/
Launched in September 2022, Femtech France aims at accelerating women's health innovation in France by fostering more collaboration within the ecosystem —founders, investors, healthcare professionals, corporates, etc.
To start Femtech France has created a bootcamp dedicated to aspiring femtech entrepreneurs who don't have a medical background. The training is divided into 3 parts: women's health, the French healthcare system, and the femtech market. Femtech France is supported by two partners for this bootcamp, Organon and Groupe VYV.
Tech4Eva - We Accelerate women's health innovation
Website: http://www.tech4eva.ch/
Tech4Eva was founded in 2021 by EPFL Innovation Park and Groupe Mutuel. It is a global FemTech community with international reach and a 9 month equity free FemTech start-up acceleration program for companies developing innovative solutions to improve technologies relating to women’s health. Solutions cover the following areas: mental health & wellbeing, period health, pregnancy & post-partum, fertility & infertility, prevention & diagnostics, menopause. We help selected start-ups companies to refine their business models and go-to-market process strategy, to meet investors and potential customers and connect them with leading FemTech hubs around the globe with the support of partners, corporate and executive mentors. To date Tech4Eva start-ups raised CHF 62+ million for women's healthcare.
Media Planet
Website: www.healthawareness.co.uk/womens-health
Mediaplanet is currently working on the Women’s Health campaign, which aims to raise awareness for key women’s health conditions including female cancers, reproductive health, and gynaecological conditions. We will highlight the importance of prevention and early diagnosis, as well as the new innovations in treatment which are helping improve patient pathways.
Euromonitor International
Website: www.euromonitor.com
Euromonitor International is a global market research company providing strategic market intelligence on industries, companies, economies and consumers around the world. Comprehensive international coverage and insights across consumer goods, business-to-business and service industries make our research an essential resource for businesses of all sizes
MassMEDIC
Website: http://www.massmedic.com/
Founded in 1996, the Massachusetts Medical Device Industry Council (MassMEDIC) is the largest regional medtech association in the United States, with over 300 members representing manufacturers, product developers, suppliers, research institutions and academic health centers.
For more than a quarter of a century, MassMEDIC has been the voice of the groundbreaking medical technology industry in New England, advocating for sound public policy that supports innovation and fostering a community built on a shared purpose.
As a MassMEDIC member, you are part of a community of innovators that believe in collaboration and collective success. Our network and resources help you navigate today’s evolving healthcare ecosystem and strengthen your goals through connection, education, awareness, and advocacy.
FemTech India
Website: https://www.femtechindia.org/
FemTech India is an authority on all things FemTech & women’s health innovations. A platform that gives a holistic outlook on everything FemTech, celebrates the intersection of an exclusive network of thinkers, innovators, and mentors while adding a layer of detail to top industry insights. The platform recognises the need that no professional in the FemTech industry should exist in a vacuum and has created a repository of content and curated experiences to enable these professionals to step up. With curated community-based events, captivating podcasts, an exclusive database, and cutting-edge industry insights, we create a rounded experience for our audience which is reflective of the times that we live in.
Our mission for this network is to connect Indian FemTech companies with the resources to learn more about the FemTech ecosystem and help them get the recognition they deserve. Become an industry leader by joining our network and be featured in our news
